4.7 Article

The impact of interrupting enzyme replacement therapy in late-onset Pompe disease

Journal

JOURNAL OF NEUROLOGY
Volume 268, Issue 8, Pages 2943-2950

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-021-10475-z

Keywords

Interruption of enzyme replacement therapy; Clinical outcome; Glycogen storage disease type 2; Pompe disease

Funding

  1. Projekt DEAL

Ask authors/readers for more resources

The interruption of enzyme replacement therapy in late-onset Pompe disease patients was associated with a deterioration in core clinical outcome measures, highlighting the importance of keeping interruptions as short as possible to maintain stable disease progression.
Background Late-onset Pompe disease (LOPD) is a rare autosomal recessive disorder caused by mutations in the GAA gene, leading to progressive weakness of locomotor and respiratory muscles. Enzyme replacement therapy (ERT), administered every second week, has been proven to slow down disease progression and stabilize pulmonary function. Due to the COVID-19 pandemic in Germany, ERT was interrupted at our centre for 29 days. As reports on ERT discontinuation in LOPD are rare, our study aimed to analyse the impact of ERT interruption on the change in clinical outcome. Methods We performed a prospective cohort study in 12 LOPD patients. Clinical assessments were performed after ERT interruption and after the next three consecutive infusions. We assessed motor function by muscle strength testing, a 6-minute-walk-test, pulmonary function tests, and adverse events. For statistical analysis, an estimated baseline was calculated based on the individual yearly decline. Results The mean time of ERT interruption was 49.42 days (SD +/- 12.54). During ERT interruption, seven patients reported 14 adverse events and two of them were severe. Frequent symptoms were reduced muscle endurance/increased muscle fatigability and shortness of breath/worsening of breathing impairment. After ERT interruption, significant deterioration was found for MIP%pred (p = 0.026) and MRC%pred, as well as a trend to clinical deterioration in FVC%pred and the 6MWT(%pred). Conclusion Interruption of ERT was associated with a deterioration in the core clinical outcome measures. Therefore, an interruption of ERT should be kept as short as possible.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available